BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 31311947)

  • 1. A Pilot Proof-Of-Principle Analysis Demonstrating Dielectrophoresis (DEP) as a Glioblastoma Biomarker Platform.
    Lewis J; Alattar AA; Akers J; Carter BS; Heller M; Chen CC
    Sci Rep; 2019 Jul; 9(1):10279. PubMed ID: 31311947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of technical and clinical utility of a bead-based flow cytometry platform for multiparametric phenotyping of CNS-derived extracellular vesicles.
    Brahmer A; Geiß C; Lygeraki A; Neuberger E; Tzaridis T; Nguyen TT; Luessi F; Régnier-Vigouroux A; Hartmann G; Simon P; Endres K; Bittner S; Reiners KS; Krämer-Albers EM
    Cell Commun Signal; 2023 Oct; 21(1):276. PubMed ID: 37803478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deep Sequencing of Small RNAs from Neurosurgical Extracellular Vesicles Substantiates miR-486-3p as a Circulating Biomarker that Distinguishes Glioblastoma from Lower-Grade Astrocytoma Patients.
    Hallal S; Ebrahim Khani S; Wei H; Lee MYT; Sim HW; Sy J; Shivalingam B; Buckland ME; Alexander-Kaufman KL
    Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32668808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid and efficient isolation and detection of extracellular vesicles from plasma for lung cancer diagnosis.
    Chen J; Xu Y; Wang X; Liu D; Yang F; Zhu X; Lu Y; Xing W
    Lab Chip; 2019 Jan; 19(3):432-443. PubMed ID: 30604797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic and prognostic value of preoperative combined GFAP, IGFBP-2, and YKL-40 plasma levels in patients with glioblastoma.
    Gállego Pérez-Larraya J; Paris S; Idbaih A; Dehais C; Laigle-Donadey F; Navarro S; Capelle L; Mokhtari K; Marie Y; Sanson M; Hoang-Xuan K; Delattre JY; Mallet A
    Cancer; 2014 Dec; 120(24):3972-80. PubMed ID: 25139333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective evaluation of serum glial fibrillary acidic protein (GFAP) as a diagnostic marker for glioblastoma.
    Tichy J; Spechtmeyer S; Mittelbronn M; Hattingen E; Rieger J; Senft C; Foerch C
    J Neurooncol; 2016 Jan; 126(2):361-9. PubMed ID: 26518540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Impact of Oncogenic EGFRvIII on the Proteome of Extracellular Vesicles Released from Glioblastoma Cells.
    Choi D; Montermini L; Kim DK; Meehan B; Roth FP; Rak J
    Mol Cell Proteomics; 2018 Oct; 17(10):1948-1964. PubMed ID: 30006486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic accuracy of cerebrospinal fluid and serum-isolated extracellular vesicles for glioblastoma: a systematic review and meta-analysis.
    Jafari D; Tiyuri A; Rezaei E; Moradi Y; Jafari R; Jokar Shoorijeh F; Barati M
    Expert Rev Mol Diagn; 2020 Nov; 20(11):1075-1085. PubMed ID: 33131342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune evasion mediated by PD-L1 on glioblastoma-derived extracellular vesicles.
    Ricklefs FL; Alayo Q; Krenzlin H; Mahmoud AB; Speranza MC; Nakashima H; Hayes JL; Lee K; Balaj L; Passaro C; Rooj AK; Krasemann S; Carter BS; Chen CC; Steed T; Treiber J; Rodig S; Yang K; Nakano I; Lee H; Weissleder R; Breakefield XO; Godlewski J; Westphal M; Lamszus K; Freeman GJ; Bronisz A; Lawler SE; Chiocca EA
    Sci Adv; 2018 Mar; 4(3):eaar2766. PubMed ID: 29532035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of glioblastoma in biofluids.
    Figueroa JM; Carter BS
    J Neurosurg; 2018 Aug; 129(2):334-340. PubMed ID: 29053069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vesiclemia: counting on extracellular vesicles for glioblastoma patients.
    Sabbagh Q; Andre-Gregoire G; Guevel L; Gavard J
    Oncogene; 2020 Sep; 39(38):6043-6052. PubMed ID: 32801336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive proteome profiling of glioblastoma-derived extracellular vesicles identifies markers for more aggressive disease.
    Mallawaaratchy DM; Hallal S; Russell B; Ly L; Ebrahimkhani S; Wei H; Christopherson RI; Buckland ME; Kaufman KL
    J Neurooncol; 2017 Jan; 131(2):233-244. PubMed ID: 27770278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Engineered nanointerfaces for microfluidic isolation and molecular profiling of tumor-specific extracellular vesicles.
    Reátegui E; van der Vos KE; Lai CP; Zeinali M; Atai NA; Aldikacti B; Floyd FP; H Khankhel A; Thapar V; Hochberg FH; Sequist LV; Nahed BV; S Carter B; Toner M; Balaj L; T Ting D; Breakefield XO; Stott SL
    Nat Commun; 2018 Jan; 9(1):175. PubMed ID: 29330365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of Tumor-Derived Extracellular Vesicles in Glioblastoma.
    Chen Y; Jin Y; Wu N
    Cells; 2021 Feb; 10(3):. PubMed ID: 33670924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Comprehensive Proteomic SWATH-MS Workflow for Profiling Blood Extracellular Vesicles: A New Avenue for Glioma Tumour Surveillance.
    Hallal S; Azimi A; Wei H; Ho N; Lee MYT; Sim HW; Sy J; Shivalingam B; Buckland ME; Alexander-Kaufman KL
    Int J Mol Sci; 2020 Jul; 21(13):. PubMed ID: 32635403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glial Fibrillary Acidic Protein in the Diagnosis and Prognosis of Malignant Glial Tumors.
    Lyubimova NV; Timofeev YS; Mitrofanov AA; Bekyashev AK; Goncharova ZA; Kushlinskii NE
    Bull Exp Biol Med; 2020 Feb; 168(4):503-506. PubMed ID: 32147765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma extracellular vesicles as a source of biomarkers in traumatic brain injury.
    Puffer RC; Cumba Garcia LM; Himes BT; Jung MY; Meyer FB; Okonkwo DO; Parney IF
    J Neurosurg; 2020 Jul; 134(6):1921-1928. PubMed ID: 32707544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An anion exchange membrane sensor detects EGFR and its activity state in plasma CD63 extracellular vesicles from patients with glioblastoma.
    Maniya NH; Kumar S; Franklin JL; Higginbotham JN; Scott AM; Gan HK; Coffey RJ; Senapati S; Chang HC
    Commun Biol; 2024 Jun; 7(1):677. PubMed ID: 38830977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genome-wide methylation profiling of glioblastoma cell-derived extracellular vesicle DNA allows tumor classification.
    Maire CL; Fuh MM; Kaulich K; Fita KD; Stevic I; Heiland DH; Welsh JA; Jones JC; Görgens A; Ricklefs T; Dührsen L; Sauvigny T; Joosse SA; Reifenberger G; Pantel K; Glatzel M; Miklosi AG; Felce JH; Caselli M; Pereno V; Reimer R; Schlüter H; Westphal M; Schüller U; Lamszus K; Ricklefs FL
    Neuro Oncol; 2021 Jul; 23(7):1087-1099. PubMed ID: 33508126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-21 in the extracellular vesicles (EVs) of cerebrospinal fluid (CSF): a platform for glioblastoma biomarker development.
    Akers JC; Ramakrishnan V; Kim R; Skog J; Nakano I; Pingle S; Kalinina J; Hua W; Kesari S; Mao Y; Breakefield XO; Hochberg FH; Van Meir EG; Carter BS; Chen CC
    PLoS One; 2013; 8(10):e78115. PubMed ID: 24205116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.